Holen Sie sich die Stockscreener-App
4.59
10.87%
-0.56
Handel nachbörslich:
4.56
-0.03
-0.65%
Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
21.82%
3.7521
|
3.0802 | 3.3084 | 2.6542 | 2.5514 |
Operating Expenses
|
21.20%
5.311
|
4.3819 | 4.5021 | 3.9398 | 3.7749 |
| Interest Income/Expense |
1.11%
0.1247
|
0.1233 | 0.126 | 0.126 | 0.1247 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
21.20%
5.311
|
4.3819 | 4.5021 | 3.9398 | 3.7749 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Operating Income/Loss |
19.75%
-1.5589
|
-1.3017 | -1.1937 | -1.2857 | -1.2236 |
| Income/Loss From Continuing Operations Before Tax |
387.26%
3.7521
|
-1.3062 | 3.3084 | 2.6542 | -1.2672 |
| Income/Loss From Continuing Operations After Tax |
20.27%
-1.571
|
-1.3062 | -1.1928 | -1.3124 | -1.2672 |
|
Net Income/Loss
|
20.27%
-1.571
|
-1.3062 | -1.1928 | -1.3124 | -1.2672 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.18%
2.5532
|
2.5487 | 0.5234 | 1.3999 | 1.3635 |
| Diluted Average Shares |
0.18%
2.5532
|
2.5487 | 0.5234 | 1.3999 | 1.3635 |
| Basic Earnings Per Share |
21.57%
-0.62
|
-0.51 | 0.20 | -0.94 | -0.93 |
| Diluted Earnings Per Share |
21.57%
-0.62
|
-0.51 | 0.20 | -0.94 | -0.93 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):